LTRN D. Jeffrey Keyser bought Lantern Pharma Inc. shares — SEC Form 4BUYLantern Pharma Inc.

D. Jeffrey Keyser, Director at Lantern Pharma Inc. (LTRN), bought 10,000 shares at $15.00 ($150K) on 2020-06-11, disclosed to the SEC on 2020-06-15.

SEC EDGAR Filing

0001213900-20-015029

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Modest59/100

Nothing distinguishes this filing.

First-Time BuyerOpportunistic Buy

Filing Info

Filed2020-06-15

Traded2020-06-11

Accession0001213900-20-015029

SourceSEC EDGAR (Historical)

Insider

NameD. Jeffrey Keyser

TitleDirector

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
LTRN	BUY	2026-05-14	$100K	—	Filing →

Get an email when an insider at LTRN files

Free account. Follow LTRN and up to 10 more companies.

Follow LTRN for free

LTRN D. Jeffrey Keyser bought Lantern Pharma Inc. shares — SEC Form 4BUYLantern Pharma Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes